UK markets closed

Coloplast A/S (CLPBY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
12.97+0.10 (+0.78%)
At close: 03:47PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
25,001,000
24,500,000
22,579,000
19,426,000
18,544,000
Cost of revenue
8,315,000
8,172,000
7,050,000
6,113,000
5,932,000
Gross profit
16,686,000
16,328,000
15,529,000
13,313,000
12,612,000
Operating expenses
Research development
889,000
872,000
866,000
755,000
708,000
Selling general and administrative
8,936,000
8,633,000
7,802,000
6,247,000
6,079,000
Total operating expenses
9,793,000
9,483,000
8,619,000
6,958,000
6,758,000
Operating income or loss
6,893,000
6,845,000
6,910,000
6,355,000
5,854,000
Interest expense
690,000
638,000
172,000
25,000
30,000
Income before tax
6,152,000
6,025,000
6,127,000
6,233,000
5,466,000
Income tax expense
1,284,000
1,242,000
1,421,000
1,408,000
1,269,000
Income from continuing operations
4,868,000
4,783,000
4,706,000
4,825,000
4,197,000
Net income
4,868,000
4,783,000
4,706,000
4,825,000
4,197,000
Net income available to common shareholders
4,868,000
4,783,000
4,706,000
4,825,000
4,197,000
Basic EPS
2.22
2.22
2.21
2.27
1.97
Diluted EPS
2.22
2.22
2.21
2.26
1.97
Basic average shares
2,154,000
2,154,000
2,125,000
2,128,000
2,126,000
Diluted average shares
2,155,000
2,155,000
2,128,000
2,132,000
2,133,000